VANCOUVER, BC – July 13, 2020 – Replicel Life Sciences Inc. (the "Company" or "Replicel")is pleased to provide this update on the status of the audit of its consolidated annual financial statements for the year ended December 31, 2019 (the “2019 Financial Statements”), the management discussion and analysis and the related officer certifications. As previously announced, the British Columbia Securities Commission issued a management cease trade order on June 17, 2020 because the Company was unable to timely file the 2019 Financial Statements, and the Company is filing this status update in accordance with National Policy 12-203, Management Cease Trade Orders, which requires bi-weekly updates by way of news releases.
The Company’s auditors are working on the audit, and the Company now expects to file the 2019 Financial Statements and related documents on or before July 30, 2020.
I am ashamed pretty bad